Gene · 10344
Papers3,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms. | Clin Rev Allergy Immunol | 2025 | 40879847 | PubTator, text mining | PubMed |
| Extracellular vesicles in intestinal protozoa: hidden mediators of host-parasite communication. | Gut Pathog | 2025 | 40877991 | PubTator, text mining | PubMed |
| Inflammatory and Mucociliary Dysfunction-Based Endotypes Across the Spectrum of Chronic Airway Diseases. | Chest | 2025 | 40876742 | PubTator, text mining | PubMed |
| Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS. | Cell | 2025 | 40865525 | PubTator, text mining | PubMed |
| Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review. | J Pers Med | 2025 | 40863432 | PubTator, text mining | PubMed |
| Coordinated changes in midkine expression and midkine-associated multiomic profile in glioma microenvironment. | Sci Rep | 2025 | 40835683 | PubTator, text mining | PubMed |
| The role of SLC2A1 in lung adenocarcinoma: From tumorigenesis to patient survival. | PLoS One | 2025 | 40824962 | PubTator, text mining | PubMed |
| Ruxolitinib, a novel JAK/STAT-targeted therapy through restoring mucosal homeostasis for chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2025 | 40774628 | PubTator, text mining | PubMed |
| A Unique Plasma Protein Signature Characterizes Squamous Cell Carcinoma of the Oral Tongue in Young Adults. | J Oral Pathol Med | 2025 | 40765509 | PubTator, text mining | PubMed |
| Real-world comparative effectiveness of biologic therapies in severe asthma: EU-ADVANTAGE. | ERJ Open Res | 2025 | 40761646 | PubTator, text mining | PubMed |
| Exploring the prognostic value and immune landscape of EGLN1 in colorectal cancer: insights from bioinformatics analysis. | Discov Oncol | 2025 | 40753313 | PubTator, text mining | PubMed |
| Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD. | Respir Res | 2025 | 40739568 | PubTator, text mining | PubMed |
| Targeting the NLRP3-ROS Axis: Disrupting the Oxidative-Inflammatory Vicious Cycle in Intracerebral Hemorrhage. | J Inflamm Res | 2025 | 40735267 | PubTator, text mining | PubMed |
| Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles. | Biomolecules | 2025 | 40723800 | PubTator, text mining | PubMed |
| Lipidomic Analysis of Esophageal Epithelia Reveals a Distinctive Sphingolipid Profile in Eosinophilic Esophagitis. | Allergy | 2025 | 40673394 | PubTator, text mining | PubMed |
| Lebrikizumab Rapidly Lowers Inflammatory Biomarkers with Clinical Correlations in Moderate-to-Severe Atopic Dermatitis. | Dermatol Ther (Heidelb) | 2025 | 40663228 | PubTator, text mining | PubMed |
| Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial. | Lancet Respir Med | 2025 | 40651490 | PubTator, text mining | PubMed |
| Non-invasive biomarkers to diagnose and monitor eosinophilic esophagitis: a systematic review. | Front Med (Lausanne) | 2025 | 40641963 | PubTator, text mining | PubMed |
| The Forgotten Innate Immune Cells: Unraveling Their Prospective Interactions with Nanomaterials. | Int J Nanomedicine | 2025 | 40584780 | PubTator, text mining | PubMed |
| Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin. | J Allergy Clin Immunol | 2025 | 40513622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10344/papers?page=7